JPMorgan Ultra Short Income ETF vs Kenvue Inc. Common Stock — how do they compare? JPMorgan Ultra Short Income ETF trades at $50.3 (market cap $42.37B), while Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B). The key difference: JPMorgan Ultra Short Income ETF is the larger of the two by market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while JPMorgan Ultra Short Income ETF pays none. Which is the better fit depends on your goals.
| JPST | KVUE | |
|---|---|---|
Market Cap | $42.37B | $34.06B |
Volume | 7,889,185 | 23,267,228 |
Sector | Fixed Income | Consumer Staples |
52-Week High | $50.78 | $19.83 |
52-Week Low | $50.22 | $14.11 |
Typical Hold Time | 47 Days | — |
Enterprise Value | — | $41.56B |
Dividend Yield | — | 4.74% |
Signals from Pluang's Aura AI — not financial advice
JPST trades at $50.27 with no recent price movement, showing stability amid bearish technical signals from moving averages. The ETF maintains consistent dividend distributions of $0.17 monthly, positioning as a cash-equivalent alternative. Recent news highlights institutional position adjustments and growing investor interest in ultra-short income strategies as rates rise.
The outlook remains stable for income-focused investors seeking minimal volatility. Key risks include interest rate sensitivity and active management performance versus peers. Recent institutional selling activity suggests some profit-taking despite the fund's role in portfolio cash management strategies.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →